Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and Xiogenix, an innovator in biopharmaceutical technology, have joined forces, enabling Cellipont Bioservices to offer its clients access to the Ares X20 fill and finish system, significantly enhancing the precision and efficiency of its cell therapy product filling processes.   The Xiogenix Ares X20 is a fill-and-finish system designed to revolutionize cell and gene therapy production. It offers...